CA Stock MarketDetailed Quotes
BETR BetterLife Pharma Inc
- 0.115
- -0.010-8.00%
15min DelayMarket Closed Nov 5 12:49 ET
14.91MMarket Cap-2875P/E (TTM)
0.125High0.110Low14.89KVolume0.125Open0.125Pre Close1.73KTurnover0.19552wk High0.02%Turnover Ratio129.66MShares0.05052wk Low-0.04EPS TTM11.33MFloat Cap30.000Historical HighLossP/E (Static)98.52MShs Float0.050Historical Low-0.03EPS LYR12.00%Amplitude--Dividend TTM-1.37P/B1Lot Size--Div YieldTTM
BetterLife Pharma Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K |
| Net income from continuing operations | -40.94%-1.45M | -112.66%-2.05M | 69.08%-2.9M | -19.62%-693.49K | 95.43%-213.74K | 8.66%-1.03M | 67.76%-963.67K | 22.92%-9.37M | 85.28%-579.76K | -111.94%-4.68M |
| Operating gains losses | 276.65%126.47K | -91.54%24.38K | -177.25%-305.18K | -987.26%-571.89K | -87.33%50.13K | -449.61%-71.59K | 812.62%288.17K | 679.32%395.06K | -177.60%-52.6K | 1,092.58%395.6K |
| Depreciation and amortization | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -0.01%18.44K | -0.02%4.61K | 0.00%4.61K |
| Remuneration paid in stock | -89.43%24.54K | 1,622.44%1.62M | -47.40%500.26K | -61.56%61.47K | -22.14%112.33K | -9.77%232.21K | -75.80%94.26K | -22.77%951.07K | -75.14%159.91K | -18.59%144.26K |
| Other non cashItems | 109.44%164.44K | 128.75%26.82K | -102.95%-90.6K | 165.88%466.22K | -115.40%-542.04K | -58.36%78.52K | -230.73%-93.3K | 215.89%3.07M | -161.85%-707.71K | 2,532.29%3.52M |
| Change In working capital | -59.23%131.28K | 28.80%-484.47K | -90.63%321.61K | -53.37%482.55K | 1,156.44%197.44K | -1.83%322.02K | -132.56%-680.4K | 360.83%3.43M | 691.06%1.03M | -356.26%-18.69K |
| -Change in receivables | -111.06%-2.65K | 192.24%17.21K | -107.21%-22.35K | -272.68%-26.71K | 92.74%-901 | 470.68%23.92K | -105.95%-18.66K | 71.25%310.01K | 105.99%15.47K | -152.49%-12.4K |
| -Change in prepaid assets | -56.43%48.94K | 74.47%-99.52K | -133.37%-198.6K | 2.96%156.25K | -2,018.67%-77.4K | 5.53%112.33K | -217.07%-389.79K | 5,685.36%595.2K | 2.46%151.76K | -99.21%4.03K |
| -Change in payables and accrued expense | -54.25%84.99K | -47.88%-402.16K | -78.54%542.56K | -59.31%353.01K | 2,772.15%275.74K | -18.53%185.77K | -118.85%-271.95K | 267.69%2.53M | 260.41%867.57K | 98.04%-10.32K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 151.79%705K | -21.94%1.24M | 87.26%2.5M | 92.12%200K | -35.09%427.4K | -13.47%280K | 538.30%1.59M | -88.11%1.34M | 67,939.87%104.1K | 658.45K |
| Net issuance payments of debt | --0 | --1.22M | --300K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | 220.45%705K | --0 | 164.19%2.2M | -79.67%100K | -15.85%287.4K | --220K | --1.59M | -92.72%833.31K | 346,211.97%491.76K | --341.55K |
| Net other financing activities | --0 | --20.24K | ---- | ---- | -55.82%140K | ---- | ---- | 751.14%502.58K | -3,524,300.00%-387.66K | --316.9K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 151.79%705K | -21.94%1.24M | 87.26%2.5M | 92.12%200K | -35.09%427.4K | -13.47%280K | 538.30%1.59M | -88.11%1.34M | 67,939.87%104.1K | --658.45K |
| Net cash flow | ||||||||||
| Beginning cash position | 70.87%422.85K | 350.03%37.38K | -95.21%8.31K | 122.34%92.62K | 323.20%60.99K | 1,618.09%247.47K | -95.21%8.31K | 12.15%173.51K | -98.05%41.66K | -99.66%14.41K |
| Current changes in cash | -59.04%-296.56K | 61.15%385.47K | 117.38%29.13K | -50.40%-55.13K | 31.40%31.53K | -7,326.05%-186.47K | 256.91%239.2K | -645.99%-167.62K | 98.12%-36.66K | 101.13%23.99K |
| Effect of exchange rate changes | 192.86%13 | 108.11%3 | -102.32%-56 | -103.11%-103 | -96.99%98 | -100.56%-14 | 99.44%-37 | 120.29%2.42K | 125.59%3.31K | -80.97%3.25K |
| End cash Position | 107.08%126.31K | 70.87%422.85K | 350.03%37.38K | 350.03%37.38K | 122.34%92.62K | 323.20%60.99K | 1,618.09%247.47K | -95.21%8.31K | -95.21%8.31K | -98.05%41.66K |
| Free cash from | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data